Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Critical Reviews in Oncology/Hematology|May 9, 2000
Telomerase: a therapeutic target for the third millennium?F Lavelle, J F Riou, A Laoui, et al.Molecular Pharmacology|October 1, 1993
Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trialsB Poddevin, J F Riou, F Lavelle, et al.FEBS Letters|November 11, 1996
Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopyI Chourpa, H Morjani, J F Riou, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivativesG J Finlay, J F Riou, B C BaguleyCancer Research|June 1, 1992
Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogeneY Pommier, A Orr, K W Kohn, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986
ATP-independent type II topoisomerase from trypanosomesS Douc-Rasy, A Kayser, J F Riou, et al.Chemical & Pharmaceutical Bulletin|April 1, 1994
Synthesis and biological properties of new benz[h]isoquinoline derivativesY L Janin, D Carrez, J F Riou, et al.Journal of Medicinal Chemistry|November 12, 1993
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivativesY L Janin, A Croisy, J F Riou, et al.Molecular Pharmacology|November 1, 1991
Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivativesJ F Riou, P Helissey, L Grondard, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP]S Douc-Rasy, J F Riou, A Kayser, et al.Pageof 11